SMTL ID : 2a8h.1 (1 other biounit)

Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.191, H.195, H.201 Ligands: 4NH.2 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.191, A:H.195, A:H.201

1 x 4NH: 4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE(Non-covalent)

4NH.2: 16 residues within 4Å: Chain A: G.132, T.133, L.134, G.135, L.136, E.184, L.187, V.188, H.191, E.192, H.195, H.201, P.223, A.225, V.226 Ligands: ZN.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.136, A:L.187, A:V.188, A:V.188, A:A.225 Hydrogen bonds: A:L.134, A:G.135, A:G.135, A:V.226 Water bridges: A:A.225, A:V.226 pi-Stacking: A:H.191

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Levin, J.I. et al., Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates. Bioorg.Med.Chem.Lett. (2006)

Release Date

2006-02-07

Peptides

ADAM 17: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ADAM 17

Related Entries With Identical Sequence